Guggenheim upgraded shares of Cardinal Health (NYSE:CAH) from a neutral rating to a buy rating in a research report released on Tuesday morning, BenzingaRatingsTable reports. Guggenheim currently has $52.00 price target on the stock, up from their previous price target of $50.00.
Separately, ValuEngine upgraded shares of Cardinal Health from a strong sell rating to a sell rating in a research note on Thursday, May 9th. Three investment analysts have rated the stock with a sell rating, five have assigned a hold rating and one has issued a buy rating to the company. The stock presently has a consensus rating of Hold and an average target price of $55.00.
Shares of CAH opened at $42.79 on Tuesday. The company has a 50-day moving average of $45.27 and a two-hundred day moving average of $47.42. The company has a debt-to-equity ratio of 1.20, a current ratio of 1.07 and a quick ratio of 0.54. The stock has a market cap of $12.99 billion, a price-to-earnings ratio of 8.25, a PEG ratio of 1.44 and a beta of 1.28. Cardinal Health has a one year low of $41.03 and a one year high of $58.31.
A number of large investors have recently added to or reduced their stakes in CAH. Bremer Bank National Association bought a new stake in Cardinal Health during the first quarter valued at about $27,000. Financial Gravity Wealth Inc. increased its holdings in shares of Cardinal Health by 258.5% in the second quarter. Financial Gravity Wealth Inc. now owns 692 shares of the company’s stock worth $33,000 after purchasing an additional 499 shares during the last quarter. SRS Capital Advisors Inc. purchased a new position in Cardinal Health in the second quarter worth about $36,000. Trustcore Financial Services LLC grew its position in Cardinal Health by 80.6% in the second quarter. Trustcore Financial Services LLC now owns 784 shares of the company’s stock worth $37,000 after acquiring an additional 350 shares in the last quarter. Finally, WealthStone Inc. purchased a new position in Cardinal Health in the second quarter worth about $38,000. 88.38% of the stock is owned by hedge funds and other institutional investors.
About Cardinal Health
Cardinal Health, Inc operates as an integrated healthcare services and products company in the United States and internationally. It provides medical products and pharmaceuticals, and solutions that enhance supply chain efficiency for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, and physician offices.
Further Reading: Oversold
Receive News & Ratings for Cardinal Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cardinal Health and related companies with MarketBeat.com's FREE daily email newsletter.